BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11523624)

  • 1. Hypercalcemia in a patient with B-cell acute lymphoblastic leukemia: a role of proinflammatory cytokine.
    Fukasawa H; Kato A; Fujigaki Y; Yonemura K; Furuya R; Hishida A
    Am J Med Sci; 2001 Aug; 322(2):109-12. PubMed ID: 11523624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypercalcemia in a child with acute nonlymphocytic leukemia: the role of parathyroid hormone-related protein and proinflammatory cytokines.
    Kounami S; Yoshiyama M; Nakayama K; Hiramatsu C; Aoyagi N; Yoshikawa N
    Acta Haematol; 2004; 112(3):160-3. PubMed ID: 15345899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels.
    Takahashi S; Hakuta M; Aiba K; Ito Y; Horikoshi N; Miura M; Hatake K; Ogata E
    Endocr Relat Cancer; 2003 Sep; 10(3):403-7. PubMed ID: 14503917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypercalcemia and multiple osteolytic lesions associated with proinflammatory cytokines in a patient with acute lymphoblastic leukemia].
    Mori A; Toyoshima N; Saito M; Oka T; Irie T; Morioka M
    Rinsho Ketsueki; 2007 Jul; 48(7):559-64. PubMed ID: 17695305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
    Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
    Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
    Motellón JL; Jiménez FJ; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Dec; 302(1-2):59-68. PubMed ID: 11074064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
    Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
    Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral hypercalcemia of malignancy with elevated plasma PTHrP, TNF alpha and IL-6 in cutaneous squamous cell carcinoma.
    Mori H; Aoki K; Katayama I; Nishioka K; Umeda T
    J Dermatol; 1996 Jul; 23(7):460-2. PubMed ID: 8772024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating parathyroid hormone-related protein (109-141) in malignancy-associated hypercalcemia.
    Nagasaki K; Otsubo K; Kajimura N; Tanaka R; Watanabe H; Tachimori Y; Kato H; Yamaguchi H; Saito D; Watanabe T; Adachi I; Yamaguchi K
    Jpn J Clin Oncol; 1996 Feb; 26(1):6-11. PubMed ID: 8551669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum concentration of parathyroid hormone-related protein and its implication in hypercalcemia in squamous cell carcinoma of the head and neck.
    Rikimaru K; Matsumoto F; Hayashi E; Bando H; Nagayama M
    Int J Oral Maxillofac Surg; 1995 Oct; 24(5):365-8. PubMed ID: 8627105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
    Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
    Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions.
    Kao PC; Klee GG; Taylor RL; Heath H
    Mayo Clin Proc; 1990 Nov; 65(11):1399-407. PubMed ID: 1700240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma.
    Wu TJ; Lin CL; Taylor RL; Kvols LK; Kao PC
    Mayo Clin Proc; 1997 Dec; 72(12):1111-5. PubMed ID: 9413289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
    Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
    Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
    Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of measuring serum parathyroid hormone-related protein concentration in leukemic patients with hypercalcemia for assessing disease status.
    Oda N; Nakai A; Hayashi R; Hayakawa N; Hamada M; Kojima K; Tsuzuki M; Matui T; Ino M; Hirano M; Iwase K; Itoh M; Nagasaka A
    Eur J Endocrinol; 1998 Sep; 139(3):323-9. PubMed ID: 9758444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.